FDA Investigator Dr. Sriram Subramaniam, PhD

Dr. Sriram Subramaniam, PhD has conducted inspections on 44 sites in 8 countries as of 12 Jan 2009. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
44
Last Inspection Date:
12 Jan 2009
Investigator Role:
FDA Investigator
Redica ID:
100006515
Countries of Inspections:
Canada, Germany, United States of America, United Kingdom of Great Britain and Northern Ireland, India, Netherlands, Czechia, Sweden
FDA Investigators that have inspected at least one site in common with Dr. Sriram Subramaniam, PhD:
Adam R Cooke, Alan E Mehl, Alan P Kurtzberg, Albert F Peacock, PhD, Allen F Hall, Amanda E Lewin, PhD, Amber G Wardwell, Amy C Jordan, Andrea A Branche, Andria L Kuhlman, Anita R Michael, Anna M Brannen, Anthony C Warchut, Anthony E Keller, RPh, Arindam Dasgupta, PhD, Barbara A Rusin, Barbara Janine Breithaupt, Barbara M Frazier, Benton M Ketron, Betsy C Galliher, Bonita S Chester, Brandon L Mariner, Brittany D Terhar, Brooke K Higgins, Brunilda Torres, Byungja E Marciante, Candice C Mandera, Candice J Cortes, Carl J Montgomery, Carla A Norris, Carla C Cummins, Carla C Tuite, Carlos Chavez, Carol Rivera Lopez, PhD, Carol S Sanchez, CDR Rochelle B Young, RPh, MSA, CDR Thomas R Berry, PPh, Chaltu Nwakijra, Charanjeet Jassal, Charles M Edwards, Chilton L Ng, Chris A Sack, Christine M Whitby, CSO, Constance Desimone, Courtney N Long, Craig A Garmendia, Cynthia A Harris, MD, RN, D'arbra R Blankenship, Dana M Klimavicz, Danial S Hutchison, Daniel J Grabicki, Daniel L Aisen, Daniel R Hurt, David M Mcnew, David R Heiar, Dawn C Olenjack, Dawn L Wydner, Dell S Moller, Denise L Burosh, Denise M Visco, Investigator, Diane Cvan Leeuwen, Dianne H Milazzo, Douglas A Campbell, Douglas C Kovacs, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dylan D Yao, MD, PhD, Edmund F Mrak, Jr, Edward D Mcdonald, Edward J Janik, Edwin Martinez, Elise A Murphy, Eric Rothschild, Eric S Weilage, Erin D Mccaffery, Erin L Mcfiren, Evelyne L Weaver, Farhana Khan, Felix Maldonado, Gabriel Davila, Gajendiran Mahadevan, PhD, Gamal A Norton, Gary J Hagan, Gary T Greco, Geoffrey K Kilili, George C Amedro, George Pyramides, Gerald Mierle, Gerald N Mcgirl, DDS, Gifford Whitehurst, Jr, Gilbert J Heidenblut, Gretchen Lf Trendel, Gulshan R Anand, Gwyn G Dickinson, Himanshu Gupta, PhD, Hugh M Mcclure, II, Huixia Zhang, Hyojong Kwon, PhD, Inga M Warr, Ingrid Y Johnson, Iris C Macinnes, Ivis L Negron, Jacqueline A O'shaughnessy, PhD, James M Kewley, James M Simpson, James P Stumpff, James R Fleckenstein, Janet L Bowen, Janete F Guardia, Jared P Stevens, Jawaid Hamid, Jeffrey J Ebersole, Jeffrey P Raimondi, Jeffrey W Shrifter, DPM, Jennifer A Longie Vollom, Jill J Tillman, Joanne M Schlossin, Jodi M Gatica, Joel D Martinez, John A Kadavil, PhD, John P Mistler, Jonee J Mearns, Jose Acruz Gonzalez, Julie N Vosilus, Justine M Corson, Ka L Wong, Kara A Scheibner, PhD, Karen E D'orazio, Karen L Kosar, Karen M Cooper, Karen M Kondas, Karen Mcnabb Noon, Kathleen B Swat, Kathleen D Culver, Kathryn A Krentz, Keith M Reilly, Kelli F Dobilas, Kellia N Hicks, Kenneth R Merritt, Kerun Hardeo, Kilili Kilili, Geoffrey K, Kip J Hanks, Kirtida Patel, Larry K Austin, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Matthew R Mcnew, MPH, REHS/RS, Leo B Zadecky, Lequita M Mayhew, Li Hongpaul Yeh, PhD, Li Li, Libia M Lugo, Linda R Kuchenthal, Lisa B Orr, Lisa P Oakes, Lori A Gioia, Lori M Newman, Luann Mckinney, Lynette P Salisbury, Marcelo O Mangalindan, Jr, Margaret E Sarles, Margaret M Annes, Martin J Guardia, Martin K Yau, PhD, Matthew C Watson, Matthew J Gretkierewicz, Matthew R Sleeter, Melkamu Getie Kebtie, PhD, Meredith L Miller, Merideth K Rose, Michael F Skelly, PhD, Michael G Sinkevich, Michael J Casey, Michael J Kuchta, Michael P Sheehan, Michael S Smoker, Michael Serrano, Michele L Obert, Michelle D Haamid, Michelle M Noe Varga, Miguel A Martinez Perez, Mike M Rashti, Mishelle L Harriger, Mohsen Rajabi Abhari, FDA, Monica E Caphart, Monique M Brooks, Muralidhara B Gavini, PhD, Nancy L Neiger, Nathaniel R Esaw, Neal L Adams, Nicholas C Mendiola, Nicola M Fenty Stewart, Nilufer M Tampal, PhD, Nutan Mytle, Olaide Akinmade, Patrick D Stone, MS, Philip F Istafanos, DMV, MS, Rachel C Harrington, Randy L Clarida, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Richard B Mcaroy, Richard H Penta, Richard L Bartlett, Richard W Berning, Rita K Kabaso, Robert Barron, Robert C Steyert, Robert D Tollefsen, Robert J Martin, Robert M Barbosa, Rory K Geyer, Rose Xu, Roy R Rinc, Ruben C Ayala, PharmD, Russ E Davis, Sam Chan, Sam H Haidar, PhD, Samuel H Chan, PharmD, Sandra A Hughes, Sarah Forney, Sarmistha Sanyal, PhD, Scott B Laufenberg, Sean Y Kassim, PhD, Sena G Dissmeyer, Seneca D Toms, Seongeun Cho (Julia), PhD, Shari H Shambaugh, Sherry L Secrist, BLT DO, Shirley H Isbill, Shirley J Berryman, Shwnji Susie Lee, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stephen J Kilker, Steven Eastham, Susan F Laska, MS, Susie H Lee, Tajah L Blackburn, Tamal K Chakraborti, PhD, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara L Greene, Tara R Gooen, Teena H Aiken, Teresa C Thompson, Terrance L Thomas, Theressa B Smith, Thomas W Nojek, Travis S Bradley, Truong Xuan Nguyen (Andy), Victoria A Wagoner, Vinh T Phan, Wayne D Mcgrath, William H Linkroum, Wr Bowman, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yih Chain Huang, PhD, Yiying E Chen, Yiyue Zhang (nmi), PhD, Yvette Mlacour Davis, Zachary A Bogorad

Dr. Sriram Subramaniam, PhD's Documents

Publish Date Document Type Title
May, 2000 FDA 483 Battelle Memorial Institute - Form 483, 2000-05-25
October, 2001 EIR Celsis In Vitro Inc. - EIR, 2001-10-12
May, 2000 FDA 483 Response Clintrials Bioresearch, Ltd. - Form 483R, 2000-06-02
March, 2000 FDA 483 AAI Pharma - Form 483, 2000-03-10
August, 2004 EIR Catalent CTS, LLC - EIR, 2004-08-20
January, 2002 EIR MDS Pharma (Dr. Wence Tong) - EIR, 2002-02-28
March, 2007 FDA 483 Response Analytical Development Corp - Form 483R, 2007-04-10
May, 2004 EIR ICON Development Solutions, LLC - EIR, 2004-05-27
September, 2007 FDA 483 Reliance Clinical Pharmacology and Pharmacokinetic FAcility - Form 483, 2007-09-12
December, 2001 FDA 483 PPD Development, L.P. - Form 483, 2001-12-19
November, 2002 FDA 483 Response Gaetano Morelli, M.D. - Form 483R, 2002-12-02
February, 2001 EIR GTF Gesellschaft für Therapeutische Forschung - EIR, 2001-02-01
April, 2003 FDA 483 Response EMINENT Services Corporation - Form 483R, 2003-05-08
November, 2001 EIR Ivax Pharmaceuticals Inc - EIR, 2001-11-29
April, 2000 FDA 483 Battelle Memorial Institute - Form 483, 2000-04-17
July, 2001 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2001-07-27
April, 2003 EIR EMINENT Services Corporation - EIR, 2003-04-02
January, 2002 FDA 483 MDS Pharma (Dr. Wence Tong) - Form 483, 2002-01-25
November, 2001 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2001-11-29
December, 2000 EIR Samuel Serfaty, M.D. - EIR, 2001-02-23
November, 2002 EIR Gary Burrs, M.D. - EIR, 2005-03-25
January, 2000 EIR Charles River Laboratories Ashland, LLC - EIR, 2000-01-28
November, 2002 FDA 483 Response Gary Burrs, M.D. - Form 483R, 2002-12-02
August, 2008 FDA 483 PPD Development, L.P. - Form 483, 2008-08-21
May, 2000 FDA 483 Response Battelle Memorial Institute - Form 483R, 2000-05-31
November, 2002 EIR Gaetano Morelli, M.D. - EIR, 2005-03-25
November, 2002 FDA 483 Gaetano Morelli, M.D. - Form 483, 2002-11-15
January, 2000 FDA 483 Charles River Laboratories Inc - Form 483, 2000-01-26
August, 2004 FDA 483 Catalent CTS, LLC - Form 483, 2004-08-20
December, 2002 FDA 483 Cetero Research - Form 483, 2002-11-01
July, 2001 EIR Catalent Pharma Solutions, LLC - EIR, 2001-07-27
January, 2002 FDA 483 Biovail Contract Research - Form 483, 2002-01-31
August, 2002 EIR Pharma Bio-Research Group Bv - EIR, 2002-09-26
January, 2000 EIR Charles River Laboratories Inc - EIR, 2000-01-26
March, 2007 FDA 483 Analytical Development Corp - Form 483, 2007-03-22
October, 2004 FDA 483 MDS Pharma Services - Form 483, 2004-09-21
April, 2003 FDA 483 EMINENT Services Corporation - Form 483, 2003-04-02
August, 2002 FDA 483 Pharma Bio-Research Group Bv - Form 483, 2002-08-29
December, 2001 EIR PPD Development, L.P. - EIR, 2001-12-19
March, 2005 FDA 483 ACCUTEST RESEARCH LABORATORIES ( I ) - Form 483, 2005-03-17
January, 2005 FDA 483 Charles River Laboratories Preclinical Services - Form 483, 2005-01-27
December, 2002 EIR Cetero Research - EIR, 2002-11-01
August, 2002 EIR NUVISAN GmbH - EIR, 2002-09-26
September, 2007 EIR Reliance Clinical Pharmacology and Pharmacokinetic FAcility - EIR, 2007-09-12
July, 2003 FDA 483 Response MDS Pharma Services - Form 483R, 2003-07-17
January, 2005 EIR Charles River Laboratories Preclinical Services - EIR, 2005-01-27
July, 2003 FDA 483 MDS Pharma Services - Form 483, 2003-07-17
May, 2004 FDA 483 ICON Development Solutions, LLC - Form 483, 2004-05-27
March, 2005 EIR ACCUTEST RESEARCH LABORATORIES ( I ) - EIR, 2005-03-17
May, 2000 FDA 483 Clintrials Bioresearch, Ltd. - Form 483, 2000-05-08
May, 2000 EIR Battelle Memorial Institute - EIR, 2000-05-25
November, 2002 FDA 483 Neopharm Labs Inc - Form 483, 2002-11-15
March, 2000 EIR AAI Pharma - EIR, 2000-03-10
October, 2001 FDA 483 Celsis In Vitro Inc. - Form 483, 2001-10-12
October, 2004 EIR MDS Pharma Services - EIR, 2007-06-15
February, 2008 FDA 483 Tandem Labs A LabCorp Company - Form 483, 2008-02-14
August, 2002 FDA 483 NUVISAN GmbH - Form 483, 2002-08-23
November, 2002 EIR Neopharm Labs Inc - EIR, 2003-01-07
August, 2002 FDA 483 Response Pharma Bio-Research Group Bv - Form 483R, 2002-09-20
August, 2004 FDA 483 Response Catalent CTS, LLC - Form 483R, 2004-08-30
November, 2002 FDA 483 Gaetano Morelli, M.D. - Form 483, 2002-11-15
May, 2000 EIR Clintrials Bioresearch, Ltd. - EIR, 2000-07-12
April, 2000 EIR Battelle Memorial Institute - EIR, 2000-04-17
July, 2003 EIR MDS Pharma Services - EIR, 2003-09-24
January, 2002 FDA 483 Response MDS Pharma (Dr. Wence Tong) - Form 483R, 2002-02-01
March, 2007 EIR Analytical Development Corp - EIR, 2007-03-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more